Travere Therapeutics Inc (TVTX)
18.25
-0.01
(-0.05%)
USD |
NASDAQ |
Nov 22, 16:00
18.27
+0.02
(+0.11%)
After-Hours: 20:00
Travere Therapeutics Total Liabilities (Quarterly): 534.86M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 534.86M |
| June 30, 2024 | 535.97M |
| March 31, 2024 | 589.48M |
| December 31, 2023 | 588.10M |
| September 30, 2023 | 553.08M |
| June 30, 2023 | 619.94M |
| March 31, 2023 | 619.09M |
| December 31, 2022 | 629.73M |
| September 30, 2022 | 625.54M |
| June 30, 2022 | 622.78M |
| March 31, 2022 | 620.26M |
| December 31, 2021 | 474.52M |
| September 30, 2021 | 467.70M |
| June 30, 2021 | 414.46M |
| March 31, 2021 | 401.36M |
| December 31, 2020 | 396.23M |
| September 30, 2020 | 390.81M |
| June 30, 2020 | 360.05M |
| March 31, 2020 | 347.32M |
| December 31, 2019 | 383.60M |
| September 30, 2019 | 367.86M |
| June 30, 2019 | 370.48M |
| March 31, 2019 | 381.96M |
| December 31, 2018 | 390.91M |
| September 30, 2018 | 397.12M |
| Date | Value |
|---|---|
| June 30, 2018 | 203.16M |
| March 31, 2018 | 201.32M |
| December 31, 2017 | 227.21M |
| September 30, 2017 | 215.99M |
| June 30, 2017 | 211.30M |
| March 31, 2017 | 209.45M |
| December 31, 2016 | 217.52M |
| September 30, 2016 | 224.82M |
| June 30, 2016 | 219.60M |
| March 31, 2016 | 187.87M |
| December 31, 2015 | 212.29M |
| September 30, 2015 | 220.62M |
| June 30, 2015 | 274.36M |
| March 31, 2015 | 247.42M |
| December 31, 2014 | 172.72M |
| September 30, 2014 | 156.12M |
| June 30, 2014 | 154.47M |
| March 31, 2014 | 129.44M |
| December 31, 2013 | 40.17M |
| September 30, 2013 | 27.17M |
| June 30, 2013 | 11.13M |
| March 31, 2013 | 8.172M |
| November 30, 2012 | 0.0687M |
| August 31, 2012 | 0.068M |
| May 31, 2012 | 0.0675M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
347.32M
Minimum
Mar 2020
629.73M
Maximum
Dec 2022
508.74M
Average
535.42M
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 62.68M |
| Electromed Inc | 7.427M |
| Xtant Medical Holdings Inc | 53.16M |
| Myomo Inc | 7.020M |
| Catheter Precision Inc | 13.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 504.41M |
| Shareholders Equity (Quarterly) | -30.45M |
| Debt to Equity Ratio | -12.43 |
| Current Ratio | 1.709 |
| Net Debt Paydown Yield | -0.04% |